Impact of Statins on Drug-Tolerant Biofilm of Mycobacteria

  • Unique Paper ID: 150390
  • Volume: 7
  • Issue: 5
  • PageNo: 149-159
  • Abstract:
  • Tuberculosis is one of the 10 leading reasons for death on the earth. Tuberculosis is an airborne bacterial contamination brought by M. tuberculosis which influences any aspect of the body and most normally the lungs. M. tuberculosis has waxy covering on its cell surface basically because of the presence of mycolic acid. As of late, a few mycobacterial species, including M. tuberculosis, have been found to shape drug-tolerant biofilms in vitro through hereditarily controlled mechanisms. Bacterial biofilms are serious worldwide wellbeing worry because of their capacities to tolerate antibiotics, host defence systems. M. tuberculosis needs cholesterol to taint and get by inside the host. Host-directed therapies are a moderately new and promising way to deal with treatment of tuberculosis. Statins are inhibitors of HMG-CoA reductase, a rate-limiting enzyme of the cholesterol biosynthesis pathway, which catalyzes transformation of HMG-CoA reductase into mevalonate and have pleiotropic impacts, including wide reach immunomodulatory, anti-inflammatory and antimicrobial effects. It has been accounted that cells treated with statins are more resistant to M. tuberculosis disease. The point of this review to assemble the accessible logical information on the biofim development by Mycobacteria tuberculosis and impact of statins on M. tuberculosis and biofilms of microorganisms.

Copyright & License

Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{150390,
        author = {Aparna gaur and K. J. Gohil},
        title = {Impact of Statins on Drug-Tolerant Biofilm of  Mycobacteria},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {7},
        number = {5},
        pages = {149-159},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=150390},
        abstract = {Tuberculosis is one of the 10 leading reasons for death on the earth. Tuberculosis is an airborne bacterial contamination brought by M. tuberculosis which influences any aspect of the body and most normally the lungs. M. tuberculosis has waxy covering on its cell surface basically because of the presence of mycolic acid. As of late, a few mycobacterial species, including M. tuberculosis, have been found to shape drug-tolerant biofilms in vitro through hereditarily controlled mechanisms. Bacterial biofilms are serious worldwide wellbeing worry because of their capacities to tolerate antibiotics, host defence systems. M. tuberculosis needs cholesterol to taint and get by inside the host. Host-directed therapies are a moderately new and promising way to deal with treatment of tuberculosis. Statins are inhibitors of HMG-CoA reductase, a rate-limiting enzyme of the cholesterol biosynthesis pathway, which catalyzes transformation of HMG-CoA reductase into mevalonate and have pleiotropic impacts, including wide reach immunomodulatory, anti-inflammatory and antimicrobial effects. It has been accounted that cells treated with statins are more resistant to M. tuberculosis disease. The point of this review to assemble the accessible logical information on the biofim development by Mycobacteria tuberculosis and impact of statins on M. tuberculosis and biofilms of microorganisms.},
        keywords = {Mycobacterium tuberculosis; cholesterol; statins; biofilms},
        month = {},
        }

Cite This Article

  • ISSN: 2349-6002
  • Volume: 7
  • Issue: 5
  • PageNo: 149-159

Impact of Statins on Drug-Tolerant Biofilm of Mycobacteria

Related Articles